Jones Financial Companies
ABVX icon

Jones Financial Companies’s Abivax ABVX Stock Holding History

Jones Financial Companies’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Sell
2,014
-2,056
-51% -$233K ﹤0.01% 2585
2026
Q1 		$417K Buy
4,070
+4,057
+31,208% +$480K ﹤0.01% 2130
2025
Q4 		$1.75K Hold
13
– – ﹤0.01% 3861
2025
Q3 		$1.08K Buy
+13
New +$797 ﹤0.01% 3871

Other funds holding ABVX

TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's ABVX Position: Q2 2026 in Review

Jones Financial Companies reduced its Abivax (ABVX) stake by 51% in Q2 2026, selling an estimated $233K and leaving 2,014 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Jones Financial Companies first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $417K in Q1 2026. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Jones Financial Companies held 2,014 shares of Abivax worth $196K as of Q2 2026.
  • Jones Financial Companies sold 2,056 Abivax shares in Q2 2026, an estimated $233K.
  • Abivax made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2585 holding.
  • Jones Financial Companies first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Jones Financial Companies's Abivax position peaked at $417K in Q1 2026.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.